EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Indazol-Pyrimidine Hybrids: Design, Synthesis, and Antiproliferative Activity Against Human Cancer Cell Lines

Hanaa M Al-Tuwaijri, Ahmed A El-Rashedy, Siddique Akber Ansari iD, Aliyah Almomen iD, Hamad M Alkahtani, Ebtehal S Al-Abdullah, Mogedda E Haiba

Molecules · 2025

DOI: 10.3390/molecules30183773 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Hanaa M Al-Tuwaijri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia. Hauptthemen laut MEDLINE: Pyrimidines, Antineoplastic Agents, Indazoles, Drug Design. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current study outlines a synthetic method for creating a new class of indazol-pyrimidine derivatives 4a–h and 5a–h. The new derivatives were evaluated as in vitro cytotoxic agents against three types of cancer cell lines (MCF-7, A549 and Caco-2), utilizing the MTT assay. Compounds 4a, 4c, 4d, 5a and 5f demonstrated potent cytotoxic activity against MCF-7 cell line, showing higher activity than the reference drug Staurosporine. Among the examined compounds, 5f showed a strong cytotoxic effect against all three tested cancer cells (MCF-7, A549 and Caco-2), with IC50 values of 1.858, 3.628 and 1.056 µM, respectively. In comparison, the reference drug exhibited IC50 values of 8.029, 7.354 and 4.202 µM respectively, indicating promising anti-proliferative potential of compound 5f. On the other hand, Compound 4b demonstrated the greatest potency against Caco-2 cell line, with an IC50 of 0.827 µM, markedly outperforming reference compound’s IC50 of 4.202 µM. Furthermore, compound 5h revealed significant anti-proliferative activity against A549 cell line, with an IC50 value of 1.378 µM, compared to the reference drug, with an IC50 value of 7.354 µM. Additionally, the molecular docking study revealed a strong binding affinity of compound 5f within the binding site of the c-Kit tyrosine kinase protein, and the molecular dynamics study confirmed its stability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimidinesAntineoplastic AgentsIndazolesDrug DesignHumansCell ProliferationMolecular Docking SimulationCaco-2 CellsCell Line, TumorStructure-Activity RelationshipDrug Screening Assays, AntitumorMolecular StructureA549 CellsMCF-7 Cells

Stichwörter der Autor:innen

cytotoxic activityindazol-pyrimidine derivativesmolecular dockingmolecular dynamics

Substanzen

PyrimidinesAntineoplastic AgentsIndazolespyrimidine

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
  • Department of Natural and Microbial Products National Research Center, El Buhouth Street, Dokki, Cairo 12622, Egypt.
  • Department Organic and Medicinal Chemistry, Faculty of Pharmacy, University of Sadat City, Menoufia 32897, Egypt.
  • Department of Therapeutic Chemistry, Pharmaceutical and Drug Industries Research Division, National Research Center, El Buhouth Street, Dokki, Cairo 12622, Egypt.

ORCID-Profile: Siddique Akber Ansari, Aliyah Almomen

Zitieren

APA

Al-Tuwaijri, H. M., El-Rashedy, A. A., Ansari, S. A., Almomen, A., Alkahtani, H. M., Al-Abdullah, E. S., & Haiba, M. E. (2025). Indazol-Pyrimidine Hybrids: Design, Synthesis, and Antiproliferative Activity Against Human Cancer Cell Lines. Molecules. https://doi.org/10.3390/molecules30183773

Vancouver

Al-Tuwaijri HM, El-Rashedy AA, Ansari SA, Almomen A, Alkahtani HM, Al-Abdullah ES, et al. Indazol-Pyrimidine Hybrids: Design, Synthesis, and Antiproliferative Activity Against Human Cancer Cell Lines. Molecules. 2025. doi:10.3390/molecules30183773

BibTeX
@article{AlTuwaijri2025,
  author = {Al-Tuwaijri, Hanaa M and El-Rashedy, Ahmed A and Ansari, Siddique Akber and Almomen, Aliyah and Alkahtani, Hamad M and Al-Abdullah, Ebtehal S and Haiba, Mogedda E},
  title = {Indazol-Pyrimidine Hybrids: Design, Synthesis, and Antiproliferative Activity Against Human Cancer Cell Lines},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30183773}
}
Kostenlos starten →